Purification and characterization of a unique human interleukin 1 from the tumor cell line U937
- PMID: 3485687
Purification and characterization of a unique human interleukin 1 from the tumor cell line U937
Abstract
Interleukin 1 (IL 1) produced by a human tumor cell line was purified to homogeneity by a three-step chromatographic method and was tested in various assays for multiple biologic properties. The purified IL 1 stimulated the proliferative response of the D10.G4.1 cell line, a mouse IL 1 indicator T cell; caused the release of prostaglandin E2 and prostacyclin from cultured human foreskin fibroblasts and from primary human umbilical vein endothelial cells; and elicited characteristic endogenous pyrogen fever in rabbits. To stimulate IL 1 production, the histiocytic lymphoma cell line U937 was incubated with the exotoxin from toxic shock strains of Staphylococcus aureus. Supernatants from stimulated U937 cells were concentrated, and were applied to a reverse-phase HPLC column. IL 1 activity was eluted from the column at high acetonitrile concentration. Subsequent chromatography over hydroxyapatite yielded a single IL 1 species with a pI of 5.5. IL 1 was then purified to homogeneity by gel exclusion HPLC migrating as a 14 kDa species. The molecular size was confirmed by SDS-PAGE and was visualized as a single molecule by silver staining; biologic activity was recovered from the same region of the gel. Limited N-terminal sequence analysis suggested some homology to the pI 7 form of the human blood monocyte IL 1. The pI 5.5 IL 1 produced by U937 cells was only partially neutralized with anti-human monocyte IL 1 antibody, suggesting that U937-derived IL 1 is structurally related to one of the molecularly cloned IL 1 species. IL 1 from stimulated U937 cells possesses the functional characteristics of monocyte IL 1 but may represent a structurally unique IL 1 species, as determined by sequence analysis, size, and antibody reactivity.
Similar articles
-
Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line.J Immunol. 1986 May 1;136(9):3304-10. J Immunol. 1986. PMID: 3485686
-
Lyme disease spirochetes induce human and murine interleukin 1 production.J Immunol. 1985 May;134(5):3147-54. J Immunol. 1985. PMID: 2984284
-
Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1.J Immunol. 1985 Sep;135(3):1872-7. J Immunol. 1985. PMID: 3874907
-
Human interleukin 1.Crit Rev Immunol. 1986;6(3):213-44. Crit Rev Immunol. 1986. PMID: 2942337 Review.
-
Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin).Year Immunol. 1986;2:68-89. Year Immunol. 1986. PMID: 3107241 Review.
Cited by
-
Analysis of carrageenan-induced suppression of antibody response.Immunology. 1990 Jun;70(2):181-5. Immunology. 1990. PMID: 2142673 Free PMC article.
-
TLR4 activation induces IL-1β release via an IPAF dependent but caspase 1/11/8 independent pathway in the lung.Respir Res. 2014 Aug 2;15(1):87. doi: 10.1186/s12931-014-0087-0. Respir Res. 2014. PMID: 25085021 Free PMC article.
-
The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.Pharm Res. 1988 Mar;5(3):129-39. doi: 10.1023/a:1015904721223. Pharm Res. 1988. PMID: 3072553 Review.
-
Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1).J Clin Immunol. 1999 Jan;19(1):1-11. doi: 10.1023/a:1020506300324. J Clin Immunol. 1999. PMID: 10080100 Review.
-
Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice.Am J Pathol. 2006 Apr;168(4):1396-403. doi: 10.2353/ajpath.2006.051054. Am J Pathol. 2006. PMID: 16565512 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous